Table 2 Interest, influence, and position of stakeholders
From: Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis
Actor/stakeholder | Interest | Influence/power | Position |
|---|---|---|---|
General population | Low | Low | Neutral |
Iranian Parliament | Moderate | High | Moderate support |
Government | High | High | High support |
Planning and Budget Organization | High | High | High support |
Ministry of Health and Medical Education (MoHME) | Moderate | High | High support |
Special Diseases Department in the MoHME | Low | Moderate | Low support |
Ministry of Cooperatives, Labour, and Social Welfare | Low | Low | Neutral |
Iran Food and Drug Administration | High | High | High support |
Health insurance organizations | Â | Â | Â |
 Social Security Organization | Low | Moderate | High support |
 Iran Health Insurance Organization | Low | Moderate | Moderate support |
 Other Health Insurance Organizations | Low | Moderate | Neutral |
Scientific associations | Low | Low | Neutral |
Support associations | High | Moderate | Moderate support |
Charity Foundation for Special Diseases | High | Moderate | Moderate support |
Media | Low | High | Neutral |
Central Bank of Iran | Moderate | High | Moderate support |
Ministry of Industry, Mining and Trade | Low | Moderate | Low support |
Pharmaceutical industry | Â | Â | Â |
 Manufacturers | Moderate | Moderate | Opposition |
 Importers | High | Moderate | Moderate support |
 Distributors and exporters | Low | Low | Neutral |
Customs Administration | Low | Low | Low support |